VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS42000759 | EBV | ENSG00000113327.17 | protein_coding | GABRG2 | No | No | 2566 | P18507 |
TVIS10003545 | HBV | ENSG00000113327.17 | protein_coding | GABRG2 | No | No | 2566 | P18507 |
TVIS10021683 | HBV | ENSG00000113327.17 | protein_coding | GABRG2 | No | No | 2566 | P18507 |
TVIS10030463 | HBV | ENSG00000113327.17 | protein_coding | GABRG2 | No | No | 2566 | P18507 |
TVIS10040017 | HBV | ENSG00000113327.17 | protein_coding | GABRG2 | No | No | 2566 | P18507 |
TVIS10034647 | HBV | ENSG00000113327.17 | protein_coding | GABRG2 | No | No | 2566 | P18507 |
TVIS10043869 | HBV | ENSG00000113327.17 | protein_coding | GABRG2 | No | No | 2566 | P18507 |
TVIS44008149 | HTLV-1 | ENSG00000113327.17 | protein_coding | GABRG2 | No | No | 2566 | P18507 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | GABRG2 |
---|---|
DrugBank ID | DB00395 |
Drug Name | Carisoprodol |
Target ID | BE0003592 |
UniProt ID | P18507 |
Regulation Type | |
PubMed IDs | 19244096; 20419052; 28642232 |
Citations | Gonzalez LA, Gatch MB, Taylor CM, Bell-Horner CL, Forster MJ, Dillon GH: Carisoprodol-mediated modulation of GABAA receptors: in vitro and in vivo studies. J Pharmacol Exp Ther. 2009 May;329(2):827-37. doi: 10.1124/jpet.109.151142. Epub 2009 Feb 24.@@Gonzalez LA, Gatch MB, Forster MJ, Dillon GH: Abuse Potential of Soma: the GABA(A) Receptor as a Target. Mol Cell Pharmacol. 2009 Jan 1;1(4):180-186.@@Kumar M, Kumar M, Freund JM, Dillon GH: A Single Amino Acid Residue at Transmembrane Domain 4 of the alpha Subunit Influences Carisoprodol Direct Gating Efficacy at GABAA Receptors. J Pharmacol Exp Ther. 2017 Sep;362(3):395-404. doi: 10.1124/jpet.117.242156. Epub 2017 Jun 22. |
Groups | Approved |
Direct Classification | Carbamate esters |
SMILES | CCCC(C)(COC(N)=O)COC(=O)NC(C)C |
Pathways | |
PharmGKB | PA448809 |
ChEMBL | CHEMBL1233 |